Addex Therapeutics Ltd (ADXN.SW)
CHF 0.06
(-8.5%)
CHF 0.06
(-8.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.95 Million | -16.43 Million | -14.7 Million | -12.18 Million | -9.48 Million | 1.75 Million |
| Net Income | -10.55 Million | -20.8 Million | -15.35 Million | -12.85 Million | -14.78 Million | -1.64 Million |
| Depreciation & Amortization | 305.95 Thousand | 323.14 Thousand | 347.61 Thousand | 378.75 Thousand | 333.84 Thousand | 2937.00 |
| Deferred income taxes | - | - | -150.59 Thousand | -27.72 Thousand | 96.53 Thousand | 20 Thousand |
| Stock-based compensation | 1.79 Million | 3.68 Million | 1.17 Million | 1.17 Million | 1.68 Million | 2.29 Million |
| Change in working capital | 213.75 Thousand | 157.67 Thousand | -761.56 Thousand | -1.82 Million | 2.65 Million | 742.72 Thousand |
| Other non-cash items | 2.86 Million | 204.13 Thousand | 32.93 Thousand | 972.63 Thousand | 523.87 Thousand | 331.92 Thousand |
| Investing Cash Flow | -6842.00 | 2972.00 | -30.31 Thousand | -59.41 Thousand | -43.25 Thousand | -61.74 Thousand |
| Investments in PPE | -6842.00 | -581.00 | -31.54 Thousand | -59.41 Thousand | -28.45 Thousand | -9054.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | -14.79 Thousand | -52.69 Thousand |
| Sales/Maturities of investments | - | 3553.00 | 1236.00 | - | - | - |
| Other Investing Activities | - | 3553.00 | 1236.00 | - | -14.79 Thousand | -5373.00 |
| Financing Cash Flow | 5.26 Million | 3.1 Million | 16.4 Million | 46.39 Thousand | -463.69 Thousand | 37.39 Million |
| Debt repayment | -281.79 Thousand | -288.07 Thousand | -309.61 Thousand | -367.41 Thousand | -316.79 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -48.05 Thousand | -307.49 Thousand | -390.18 Thousand | - | - | -5373.00 |
| Common Stock Issuance | 5.52 Million | 3.41 Million | 13.95 Million | 720.01 Thousand | 5986.00 | 40.48 Million |
| Other Financing Activities | 5.59 Million | 3.69 Million | 3.53 Million | -306.2 Thousand | -152.88 Thousand | -3.09 Million |
| Accounts receivables | 447.04 Thousand | -252.09 Thousand | -96.41 Thousand | 49.65 Thousand | 154.98 Thousand | 30.86 Thousand |
| Accounts payables | -613.2 Thousand | -427.38 Thousand | 883.83 Thousand | -1.58 Million | 1.96 Million | 1.08 Million |
| Inventory | - | 427.38 Thousand | -883.83 Thousand | 1.53 Million | -2.12 Million | - |
| Other working capital | 379.91 Thousand | 409.76 Thousand | -665.15 Thousand | -1.82 Million | 2.65 Million | 742.72 Thousand |
| Cash at beginning of period | 6.95 Million | 20.48 Million | 18.69 Million | 31.53 Million | 41.67 Million | 2.57 Million |
| Cash at end of period | 3.86 Million | 6.95 Million | 20.48 Million | 18.69 Million | 31.53 Million | 41.67 Million |
| Capital Expenditure | -6842.00 | -581.00 | -31.54 Thousand | -59.41 Thousand | -28.45 Thousand | -9054.00 |
| Effect of forex changes on cash | -356.94 Thousand | -196.22 Thousand | 122.47 Thousand | -648.68 Thousand | -144.3 Thousand | 10.46 Thousand |
| Net cash flow / Change in cash | -3.09 Million | -13.52 Million | 1.78 Million | -12.84 Million | -10.13 Million | 39.09 Million |
| Free Cash Flow | -7.95 Million | -16.43 Million | -14.73 Million | -12.23 Million | -9.51 Million | 1.74 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 12.87 Million | -735.17 Thousand | -10.55 Million | -2.85 Million | -2.61 Million | -2.67 Million |
| Depreciation & Amortization | 112.38 Thousand | 2938.00 | 305.95 Thousand | 79.38 Thousand | 75.38 Thousand | 75.4 Thousand |
| Deferred income taxes | - | - | - | - | -5267.00 | -9149.00 |
| Stock-based compensation | - | 386.02 Thousand | 1.79 Million | 389.2 Thousand | 483.46 Thousand | 490.6 Thousand |
| Change in working capital | -2.36 Million | 562.85 Thousand | 213.75 Thousand | 1.58 Million | -151.1 Thousand | -778.09 Thousand |
| Other non-cash items | 44.8 Thousand | -2.87 Million | 2.86 Million | -117.53 Thousand | -37.53 Thousand | 138.56 Thousand |
| Investing Cash Flow | 4.66 Million | - | -6842.00 | -1205.00 | -678.00 | -2490.00 |
| Investments in PPE | 2.00 | - | -6842.00 | -1205.00 | -678.00 | -2490.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 4.66 Million | - | - | - | - | - |
| Financing Cash Flow | -57.41 Thousand | 163.27 Thousand | 5.26 Million | -58.35 Thousand | -188.96 Thousand | 4.48 Million |
| Debt repayment | -3003.00 | -66.73 Thousand | -281.79 Thousand | -69.05 Thousand | -72.12 Thousand | -26.59 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -4546.00 | -48.05 Thousand | -3302.00 | -18.33 Thousand | -15.23 Thousand |
| Common Stock Issuance | -55.05 Thousand | 230.01 Thousand | 5.52 Million | 27.17 Thousand | -126.98 Thousand | 4.49 Million |
| Other Financing Activities | 219.69 Thousand | 779.00 | 5.59 Million | 14 Thousand | -98.5 Thousand | 4.52 Million |
| Accounts receivables | -471.4 Thousand | -73.77 Thousand | 447.04 Thousand | 214.43 Thousand | 71.38 Thousand | -25.24 Thousand |
| Accounts payables | -1.94 Million | 931.15 Thousand | -613.2 Thousand | 638.69 Thousand | -685.01 Thousand | -572.08 Thousand |
| Inventory | - | - | - | - | 685.01 Thousand | 572.08 Thousand |
| Other working capital | -23.64 Thousand | -294.52 Thousand | 379.91 Thousand | 729.24 Thousand | -222.49 Thousand | -752.84 Thousand |
| Cash at beginning of period | 1.62 Million | 3.86 Million | 6.95 Million | 4.75 Million | 7.16 Million | 5.59 Million |
| Cash at end of period | 3.78 Million | 1.62 Million | 3.86 Million | 3.86 Million | 4.75 Million | 7.16 Million |
| Capital Expenditure | 2.00 | - | -6842.00 | -1205.00 | -678.00 | -2490.00 |
| Effect of forex changes on cash | 1631.00 | 97.99 Thousand | -356.94 Thousand | -206.04 Thousand | 26.8 Thousand | -149.05 Thousand |
| Net cash flow / Change in cash | 2.15 Million | -2.23 Million | -3.09 Million | -888.62 Thousand | -2.41 Million | 1.57 Million |
| Free Cash Flow | -2.75 Million | -2.19 Million | -7.95 Million | -619.45 Thousand | -2.25 Million | -2.76 Million |
CHRTEDCA
FF24
2475
8961
603976
CLIS